Clinical implications of reinforcement as a determinant of substance use disorders - PubMed (original) (raw)
Review
Clinical implications of reinforcement as a determinant of substance use disorders
Stephen T Higgins et al. Annu Rev Psychol. 2004.
Abstract
Extensive scientific evidence indicates that reinforcement plays an important role in the genesis, maintenance, and recovery from substance use disorders. In this chapter, we review recent clinical research from laboratory, clinic, and naturalistic settings examining the role of reinforcement in substance use disorders. Well-controlled human laboratory studies are reviewed characterizing orderly interactions between the reinforcing effects of drugs and environmental context that have important implications for understanding risk factors for substance use disorders and for the development of efficacious interventions. Recent treatment-outcome studies on voucher-based contingency management and community reinforcement therapy are reviewed demonstrating how reinforcement and related principles can be used to improve outcomes across a wide range of different substance use disorders and populations. Overall, the chapter characterizes a vigorous area of clinical research that has much to contribute to a scientific analysis of substance use disorders.
Similar articles
- Investigating the pharmacological and nonpharmacological factors that modulate drug reinforcement.
Sigmon SC. Sigmon SC. Exp Clin Psychopharmacol. 2007 Feb;15(1):1-20. doi: 10.1037/1064-1297.15.1.1. Exp Clin Psychopharmacol. 2007. PMID: 17295581 Review. - A meta-analysis of voucher-based reinforcement therapy for substance use disorders.
Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. Lussier JP, et al. Addiction. 2006 Feb;101(2):192-203. doi: 10.1111/j.1360-0443.2006.01311.x. Addiction. 2006. PMID: 16445548 Review. - The reinforcing functions of drugs and assessment of abuse liability.
Brady J. Brady J. NIDA Res Monogr. 1988;81:440-56. NIDA Res Monogr. 1988. PMID: 3136383 Review. No abstract available. - The role of impulsivity in the development of substance use and eating disorders.
Dawe S, Loxton NJ. Dawe S, et al. Neurosci Biobehav Rev. 2004 May;28(3):343-51. doi: 10.1016/j.neubiorev.2004.03.007. Neurosci Biobehav Rev. 2004. PMID: 15225976 Review. - Potential sources of reinforcement and punishment in a drug-free treatment clinic: client and staff perceptions.
Roll JM, Chudzynski JE, Richardson G. Roll JM, et al. Am J Drug Alcohol Abuse. 2005;31(1):21-33. Am J Drug Alcohol Abuse. 2005. PMID: 15768569
Cited by
- Is exposure to an effective contingency management intervention associated with more positive provider beliefs?
Kirby KC, Carpenedo CM, Stitzer ML, Dugosh KL, Petry NM, Roll JM, Saladin ME, Cohen AJ, Hamilton J, Reese K, Sillo GR, Stabile PQ, Sterling RC. Kirby KC, et al. J Subst Abuse Treat. 2012 Jun;42(4):356-65. doi: 10.1016/j.jsat.2011.09.004. Epub 2011 Nov 23. J Subst Abuse Treat. 2012. PMID: 22116009 Free PMC article. - Financial incentives for smoking cessation among pregnant and newly postpartum women.
Higgins ST, Washio Y, Heil SH, Solomon LJ, Gaalema DE, Higgins TM, Bernstein IM. Higgins ST, et al. Prev Med. 2012 Nov;55 Suppl(Suppl):S33-40. doi: 10.1016/j.ypmed.2011.12.016. Epub 2011 Dec 27. Prev Med. 2012. PMID: 22227223 Free PMC article. Review. - Mechanisms of resurgence II: Response-contingent reinforcers can reinstate a second extinguished behavior.
Winterbauer NE, Bouton ME. Winterbauer NE, et al. Learn Motiv. 2011 May 1;42(2):154-164. doi: 10.1016/j.lmot.2011.01.002. Learn Motiv. 2011. PMID: 21479120 Free PMC article. - Alcohol use disorder symptoms are associated with greater relative value ascribed to alcohol, but not greater discounting of costs imposed on alcohol.
Hogarth L, Hardy L. Hogarth L, et al. Psychopharmacology (Berl). 2018 Aug;235(8):2257-2266. doi: 10.1007/s00213-018-4922-8. Epub 2018 May 9. Psychopharmacology (Berl). 2018. PMID: 29744556 Free PMC article. - Contingency management for college student smokers: The role of drinking as a moderator and mediator of smoking abstinence during treatment.
Cassidy RN, Jackson KM, Rohsenow DJ, Tidey JW, Tevyaw TOL, Barnett NP, Monti PM, Miller ME, Colby SM. Cassidy RN, et al. Addict Behav. 2018 May;80:95-101. doi: 10.1016/j.addbeh.2018.01.017. Epub 2018 Jan 31. Addict Behav. 2018. PMID: 29367116 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical